Industries de la santé

The Quadro Ytron® HV-Emulsifier Group Seri

Waterloo, Canada, July 11, 2012 - Size Reduction or Milling of APIs (Active Pharmaceutical Ingredients) is a key step in the drug development process. When milling an API, the developer requires a tight particle size distribution that ensures consistent drug substance and drug product quality. Traditionally, dry milling technologies such as...

Création de Vexim Italie, deuxième filiale de Vexim après l'Allemagne


Toulouse, le 6 juillet 2012 - Vexim (FR0011072602 ALVXM), société de dispositifs médicaux  spécialisée dans le traitement mini-invasif des fractures vertébrales, annonce la création de sa filiale italienne à Milan. Disposant déjà d'une forte notoriété en Italie, la filiale va permettre à Vexim...

LONDON, UK (GlobalData), 3 July 2012 - While the world focused on the fate of the Affordable Care Act, another important piece of healthcare legislation worked its way through Congress, the Prescription Drug User Fee Act (PDUFA) V. First introduced in 1992, PDUFA authorizes the FDA to collect fees from companies seeking approval of new drugs. The FDA uses these funds to hasten the drug...

Le Syndicat de l’Industrie du Diagnostic In Vitro (SIDIV), membre de droit de l’Alliance pour la Recherche et l’Innovation des Industries de Santé (ARIIS), y apporte une contribution active avec l’intention de promouvoir un environnement compétitif en France et de créer de la valeur dans le domaine de la recherche et de l’innovation pour les industries de santé.


Face aux enjeux...

NEW YORK (GBI Research), 26 June 2012 - Continuous support from the government is helping the Brazilian pharmaceutical market to grow at a compound annual growth rate (CAGR) of 9%, and to make its own mark on the global industry, says a new report by healthcare experts GBI Research.

The new report* states that Brazil has a population of around 190 million, representing a gigantic...

LONDON, UK (GlobalData), 25 June 2012 - The in-vitro diagnostic industry is witnessing companion diagnostics emerge as the next big thing, as attention in the pharmaceutical industry shifts from blockbuster drugs to personalized medical treatment, says a new report by healthcare experts GlobalData.

The new report* states that the companion diagnostics industry is being spurred on as the...

NEW YORK (GBI Research), 21 June 2012 - Argentina is boosting the health of their citizens thanks to strong government schemes that are providing medical attention to those that need it, while financially supporting the country’s in-house pharmaceutical production, according to a new report from healthcare experts GBI Research.

The new report shows that the Argentine pharmaceutical market...

LONDON, UK (GlobalData), 20 June 2012 - European healthcare is being transformed as a result of economic recession, as austerity measures reshape the way that countries run, states a new report by healthcare experts GlobalData.

The new report* looks at the sovereign debt crisis, formed by a collection of budget deficits created by insufficient tax revenue and excessive spending in across...

HAIFA, ISRAEL – June 19, 2012 -- Pluristem Therapeutics, Inc. (NASDAQCM:PSTI; TASE: PLTR) announced today at the 2012 Bio International Convention the results of a pre clinical study it conducted measuring the effectiveness of its Placental eXpanded (PLX) cells when administered intramuscularly(IM). Cell therapies are traditionally delivered through intravenous (IV) injections for...

Vitrines Sociétés

Voir toutes les vitrines